The other renal features reported at baseline were multiple renal cysts (24.6%), polycystic kidney disease (proven TSC2/PKD1 mutation; 3.4%), renal malignancy (1.4%), and impaired renal function (non-angiomyolipoma-related; 1.9%) (Table 6). Here, TSC2 is linked to polycystic kidney disease.